Exposure to Volatile Organic Compounds and Use of Feminine Hygiene Products Among Reproductive-Aged Women in the United States

被引:20
|
作者
Ding, Ning [1 ]
Batterman, Stuart [2 ,3 ]
Park, Sung Kyun [1 ,2 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA
[3] Coll Engn, Dept Water Resources & Environm Engn, Ann Arbor, MI USA
关键词
feminine hygiene practices; volatile organic compounds; health disparities; ORAL-MUCOSA; DICHLOROBENZENE; SKIN; PERMEABILITY; PENETRATION; TOXICITY; ROUTE; WATER; LIMIT;
D O I
10.1089/jwh.2019.7785
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Feminine hygiene products (FHPs) are personal care products widely used by women. A few studies have detected some volatile organic compounds (VOCs) in FHPs, but no previous epidemiological studies have linked use of these products to human exposure to VOCs using biomarkers. Therefore, we evaluated whether the use of FHPs was associated with VOC exposures among reproductive-aged women in the United States. Materials and Methods: Data on 2432 women aged 20-49 years from National Health and Nutrition Examination Survey 2001-2004 were utilized. Self-reported use of feminine products (tampons, sanitary napkins, vaginal douches, sprays, powders, wipes/towelettes, and other products) was obtained from questionnaires. Survey-weighted linear regression models were used to estimate percent changes in VOC whole blood concentrations and 95% confidence intervals (CIs). Results: Black women had significantly more use of vaginal douching and significantly higher whole blood concentrations of 1,4-dichlorobenzene (DCB) (p < 0.0001). After adjusting for confounders, we observed a dose-response relationship between the frequency of vaginal douching in the past 6 months and 1,4-DCB concentrations. Compared with never users, women with occasional use (<= 1 time/month) of vaginal douching had 18% (95% CI: -12% to 59%) higher concentrations, and those with frequent use (>= 2 time/month) had 81% (95% CI: 2% to 221%) higher concentrations of 1,4-DCB (p for trend = 0.04). Use of feminine powder in the past month was significantly associated with 36% (95% CI: 0.4% to 83%) higher concentrations of ethylbenzene. Conclusions: Our findings suggest that differences in whole blood VOC concentrations might be explained by feminine hygiene practices. The presence of environmental chemicals in FHPs warrants further examination.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 50 条
  • [11] Pregnancies Among Reproductive-Aged Human Immunodeficiency Virus-Infected Women in Care, United States
    Sutton, Madeline Y.
    Frazier, Emma
    Short, William
    Skarbinski, Jacek
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 33S - 34S
  • [12] Treatments for opioid use disorder among pregnant and reproductive-aged women
    Hand, Dennis J.
    Short, Vanessa L.
    Abatemarco, Diane J.
    FERTILITY AND STERILITY, 2017, 108 (02) : 222 - 227
  • [13] Volatile organic compounds in feminine hygiene products sold in the US market: A survey of products and health risks
    Lin, Nan
    Ding, Ning
    Meza-Wilson, Emily
    Devasurendra, Amila Manuradha
    Godwin, Christopher
    Park, Sung Kyun
    Batterman, Stuart
    ENVIRONMENT INTERNATIONAL, 2020, 144
  • [14] The use of fertility treatments among reproductive-aged women after cancer
    Kipling, Lauren M.
    Shandley, Lisa M.
    Mertens, Ann C.
    Spencer, Jessica B.
    Howards, Penelope P.
    FERTILITY AND STERILITY, 2024, 121 (04) : 578 - 588
  • [15] Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019
    Duchesneau, Emilie D.
    Kinlaw, Alan C.
    Jonsson Funk, Michele
    Pate, Virginia
    Lund, Jennifer L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (04) : 481 - 487
  • [16] Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States 2001-2017
    Duchesneau, Emilie D.
    Funk, Michele Jonsson
    Kinlaw, Alan C.
    Lund, Jennifer L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 239 - 239
  • [17] Obesity Prevalence Among Reproductive-Aged Women by Number of Live Births United States, 2001-2010
    Moniz, Michelle H.
    Chang, Tammy
    Choi, HwaJung
    Davis, Matthew M.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 158S - 158S
  • [18] Association between visceral adiposity index and infertility in reproductive-aged women in the United States
    Zhuang, Jiaru
    Wang, Yuan
    Wang, Shan
    Hu, Renjing
    Wu, Yibo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [19] Perceived harms of and exposure to tobacco use and current tobacco use among reproductive-aged women from the PATH study
    Do, Elizabeth K.
    Nicksic, Nicole E.
    Clifford, James S.
    Hayes, Alishia
    Fuemmeler, Bernard F.
    WOMEN & HEALTH, 2020, 60 (09) : 1040 - 1051
  • [20] Herbal Supplement Use Among Reproductive-Aged Women in an Academic Infertility Practice
    Friedman, Julie C.
    Sheeder, Jeanelle
    Lazorwitz, Aaron
    Polotsky, Alex J.
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 177 - 178